Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors
Public ClinicalTrials.gov record NCT00510068. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Double-blind Phase III Study of RAD001 10 mg/d Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Neuroendocrine Tumor (NET)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to evaluate progression free survival in those participants assigned everolimus 10 mg/day plus Best Supportive Care versus those assigned to placebo plus Best Supportive Care in Advanced Neuroendocrine Tumors of pancreatic origin.
Study identification
- NCT ID
- NCT00510068
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 410 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2007 (Type not available)
- Primary completion
- Feb 2010 (Actual)
- Completion
- Mar 2014 (Actual)
- Last update posted
- Jul 1, 2015
2007 – 2014
United States locations
- U.S. sites
- 24
- U.S. states
- 18
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Alabama / Mitchell Cancer Institute Deptof Mitchell Cancer Inst(2) | Mobile | Alabama | 36688 | — |
| Pacific Cancer Medical Center, Inc. | Anaheim | California | 92801 | — |
| Cedars Sinai Medical Center SC-2 | Los Angeles | California | 90048 | — |
| University of California at Los Angeles UCLA (3) | Los Angeles | California | 90095 | — |
| University of California San Francisco Dept. of UCSF Comp. Cancer | San Francisco | California | 94143-0128 | — |
| Kaiser Permanente Northwest Franklin Medical Offices | Denver | Colorado | — | — |
| H. Lee Moffitt Cancer Center & Research Institute Malignant Hematology Clinic | Tampa | Florida | 33612 | — |
| Indiana University Health Goshen Center for Cancer Dept. of Indiana Univ. Cancer | Indianapolis | Indiana | 46202 | — |
| University of Iowa Medical Center Dept. of Iowa Medical Center | Iowa City | Iowa | 52242 | — |
| University of Louisville / James Graham Brown Cancer Center SC | Louisville | Kentucky | 40202 | — |
| LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Dept. of Neuroendocrine Clinic | New Orleans | Louisiana | 70115 | — |
| Boston Medical Center BMC | Boston | Massachusetts | 02118 | — |
| Wayne State University/Karmanos Cancer Institute Dept.of KarmanosCancerInst (4) | Detroit | Michigan | 48201 | — |
| Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | — |
| Littleton Regional Hospital Dept. of Hematology/Oncology | Littleton | New Hampshire | 03561 | — |
| Columbia University Medical Center- New York Presbyterian Dept. of Columbia Med. Center | New York | New York | 10032 | — |
| Levine Cancer Institute | Charlotte | North Carolina | 28203 | — |
| Ohio State Comprehensive Cancer Center/James Cancer Hospital Dept. of OHSU Medical Center | Columbus | Ohio | 43210 | — |
| Oregon Health & Science University Dept. of OHSU (3) | Portland | Oregon | 97239 | — |
| St. Luke's Hospital and Health Network St. Luke's Cancer Network | Bethlehem | Pennsylvania | — | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111-2497 | — |
| University of Pittsburgh Medical Center Hillman Cancer Center | Pittsburgh | Pennsylvania | 15213 | — |
| The Center for Cancer and Blood Disorders | Fort Worth | Texas | 76104 | — |
| University of Texas/MD Anderson Cancer Center Dept of MD Anderson CancerCent | Houston | Texas | 77030-4009 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00510068, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2015 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00510068 live on ClinicalTrials.gov.